Visby Medical vs Neuralink
Side-by-side comparison of AI visibility scores, market position, and capabilities
Visby Medical makes single-use handheld PCR diagnostic devices for point-of-care testing; received FDA EUA for COVID-19, flu A/B, and RSV tests; raised $250M+ total; partnered with Pfizer for commercialization;
About
Visby Medical is a San Jose, California-based medical diagnostics company that has developed a novel point-of-care PCR testing platform. Unlike conventional PCR testing, which requires large laboratory instruments and trained technicians, Visby's devices are single-use, handheld, and self-contained — delivering lab-accurate polymerase chain reaction results in under 30 minutes without any external reader or instrument. The disposable form factor allows testing at the point of care in clinics, pharmacies, urgent care centers, and even at home, eliminating the logistical overhead of sending samples to reference laboratories.
Pioneer of implantable BCIs with 12+ active human patients as of Sep 2025; raised $650M Series E in Apr 2026 led by ARK Invest and Sequoia at a ~$14.9B valuation; mass production underway.
About
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with paralysis to control digital devices directly with their thoughts. The company's first commercial product, the N1 implant, is a coin-sized device containing 1,024 electrodes that is surgically placed in the motor cortex. As of September 2025, twelve patients worldwide had received the N1 implant and were actively using it to control computers, smartphones, and robotic arms with neural signals alone.
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.